In vivo evidence for the role of CD44s in promoting breast cancer metastasis to the liver.
about
Aberrant Splicing of Estrogen Receptor, HER2, and CD44 Genes in Breast CancerMechanisms involved in breast cancer liver metastasisWNT5A signaling impairs breast cancer cell migration and invasion via mechanisms independent of the epithelial-mesenchymal transitionLysosomal degradation of CD44 mediates ceramide nanoliposome-induced anoikis and diminished extravasation in metastatic carcinoma cells.Identification of proteins secreted from leptin stimulated MCF-7 breast cancer cells: a dual proteomic approach.In situ identification of putative cancer stem cells by multiplexing ALDH1, CD44, and cytokeratin identifies breast cancer patients with poor prognosis.Fish oil prevents breast cancer cell metastasis to bone.Overexpression of CD44 accompanies acquired tamoxifen resistance in MCF7 cells and augments their sensitivity to the stromal factors, heregulin and hyaluronan.Simvastatin prevents skeletal metastasis of breast cancer by an antagonistic interplay between p53 and CD44.Survivin is a novel target of CD44-promoted breast tumor invasionCD44 increases the efficiency of distant metastasis of breast cancerSuppression of human breast tumors in NOD/SCID mice by CD44 shRNA gene therapy combined with doxorubicin treatmentCD44 enhances invasion of basal-like breast cancer cells by upregulating serine protease and collagen-degrading enzymatic expression and activity.Loss of plakoglobin promotes decreased cell-cell contact, increased invasion, and breast cancer cell dissemination in vivoCD44-mediated activation of α5β1-integrin, cortactin and paxillin signaling underpins adhesion of basal-like breast cancer cells to endothelium and fibronectin-enriched matrices.The hyaluronan synthesis inhibitor 4-methylumbelliferone exhibits antitumor effects against mesenchymal-like canine mammary tumor cells.Separation and Characterization of Epithelial and Mesenchymal-like Murine Mammary Tumor Cells Reveals Epithelial Cell Differentiation Plasticity and Enhanced Tumorigenicity of Epithelial-enriched Tumor Cells.In vivo monitoring of CD44+ cancer stem-like cells by γ-irradiation in breast cancer.Regulation of CD44 expression and focal adhesion by Golgi phosphatidylinositol 4-phosphate in breast cancer.Targeting cancer stem cells with monoclonal antibodies: a new perspective in cancer therapy and diagnosis.Tamoxifen resistance in breast cancer.Size-dependent regulation of Snail2 by hyaluronan: its role in cellular invasion.Breast cancer cells expressing stem cell markers CD44+ CD24 lo are eliminated by Numb-1 peptide-activated T cells.DHA is a more potent inhibitor of breast cancer metastasis to bone and related osteolysis than EPA.Interstitial cell migration: integrin-dependent and alternative adhesion mechanisms.Hyaluronan: a simple polysaccharide with diverse biological functions.Microenvironmental networks promote tumor heterogeneity and enrich for metastatic cancer stem-like cells in Luminal-A breast tumor cells.Breast cancer stem cells and their role in resistance to endocrine therapy.Nanoparticle mediated targeting of VEGFR and cancer stem cells for cancer therapyEmbryonic stem cell-specific signature in cervical cancer.CD44 expression contributes to trastuzumab resistance in HER2-positive breast cancer cells.Hyaluronic acid functional amphipathic and redox-responsive polymer particles for the co-delivery of doxorubicin and cyclopamine to eradicate breast cancer cells and cancer stem cells.FOXP3 suppresses breast cancer metastasis through downregulation of CD44.TGF-β2: A Novel Target of CD44-Promoted Breast Cancer Invasion.Extracellular ATP induces CD44 shedding from macrophage-like P388D1 cells via the P2X7 receptor.Plasma hyaluronic acid level as a prognostic and monitoring marker of metastatic breast cancer.Prognostic Value of Cancer Stem Cells Markers in Triple-Negative Breast Cancer.Therapeutic Targeting of Circulating Tumor Cells: An Important Problem That Deserves Careful Study.Akt Signaling Is Sustained by a CD44 Splice Isoform-Mediated Positive Feedback Loop.Quantitative assessment of CD44 genetic variants and cancer susceptibility in Asians: a meta-analysis.
P2860
Q26773907-E52066BA-2A33-439D-ACBB-09454EAE795FQ28084024-4BFFEEAC-0652-4216-96C2-9C59621AD213Q28595799-08D08E41-BC65-4319-89BE-597B5BC58CCDQ30300775-FCA30DD2-8266-45D6-93CC-5DA98ECBAB01Q33327933-28192DF1-4C86-427E-8E75-A65781F87B94Q33816271-29846074-16A8-4711-B534-701E9E0F8DDDQ34361670-B07F2B21-D1A3-4FD2-848C-60BC79CEBDDBQ34435089-40E6296D-B09B-4A74-9D9B-DEDA4EAB42B1Q34719626-C875DD65-0061-4261-9A05-498E92A1A60EQ35168013-149A8555-9DF9-4793-AEB9-C4EB02F54B1CQ35793831-DFED5FB2-D43B-4711-87B3-29E4793E8830Q35979751-462249F7-13FC-47AB-8C40-E248AC1D0DC5Q36245396-A0738D7C-6028-40A4-BDCA-D9D92FC782FEQ36245406-C3CB5FFB-08B8-4E36-8890-131133D4AAF1Q36546783-67D84DE0-8DD4-43BB-8589-D20DF37241EEQ36621561-393D68C2-34C9-4CA5-AB71-456B229FA22AQ36695069-025FF9D6-A58B-479B-A567-DAEA3103F3EDQ36892916-E1812142-765D-4098-9741-3233FC75977BQ37098317-3F166076-DC64-4458-93D3-C01451A08BC8Q37206241-84C5EA31-2FF2-49B4-8F6C-703E488F91E4Q37224555-E8EAF8FE-5678-4EDE-AFB0-4E148CD5C41DQ37248258-E37A8CA3-2DED-4760-9F18-FF76CCF24670Q37304940-EF42B900-993C-401D-9207-F4A2D05BB069Q37339672-CA309E9F-9671-4DF1-B1B2-0E3F15CD4B2CQ37634379-00413613-FF07-4923-BE5D-18B4BD1EB2F7Q37649833-E9766D50-8B07-451E-99B3-67B589193320Q37697134-239D7460-3965-4CEF-9155-BF883B60EE70Q37901429-76113227-7F8C-46C3-9E28-A7A25F19369DQ37955957-77506B38-9BA5-4409-9AFC-8A9065521B91Q38155818-38B1B8F0-9526-4AA6-9A82-B72F4FFD8601Q38875316-C06625DD-F432-4DCF-9A29-2B4B33CDFD0EQ38883912-25BDCD48-C88F-4232-ACD1-0FBC5D61A4A6Q38909359-8E09D833-2873-4040-BC62-2CA6506747D7Q39103885-EEB6E4B9-3F46-465A-B3ED-4431DA1A0E2AQ39496033-CAA4FD87-BF79-44D5-A235-FB7C8DC98508Q41035419-04B50E00-986F-449C-AD9F-5E335ECB15B4Q41182171-023427E4-40B1-41AD-8BD4-FDFE31C9EE08Q41343831-F3E09613-A466-470A-BAE9-426BFB5D10EDQ41546742-47298977-E971-4E92-883C-D793BAA27A92Q42317546-6902C224-4044-4881-B5DB-3D7ED63DE313
P2860
In vivo evidence for the role of CD44s in promoting breast cancer metastasis to the liver.
description
2007 nî lūn-bûn
@nan
2007 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
In vivo evidence for the role ...... ancer metastasis to the liver.
@ast
In vivo evidence for the role ...... ancer metastasis to the liver.
@en
In vivo evidence for the role ...... ancer metastasis to the liver.
@nl
type
label
In vivo evidence for the role ...... ancer metastasis to the liver.
@ast
In vivo evidence for the role ...... ancer metastasis to the liver.
@en
In vivo evidence for the role ...... ancer metastasis to the liver.
@nl
prefLabel
In vivo evidence for the role ...... ancer metastasis to the liver.
@ast
In vivo evidence for the role ...... ancer metastasis to the liver.
@en
In vivo evidence for the role ...... ancer metastasis to the liver.
@nl
P2093
P2860
P1476
In vivo evidence for the role of CD44s in promoting breast cancer metastasis to the liver
@en
P2093
Allal Ouhtit
Madhwa H G Raj
Mohamed E Abdraboh
Tong F Lioe
P2860
P304
P356
10.2353/AJPATH.2007.070535
P407
P577
2007-11-08T00:00:00Z